News
Kim Kardashian posted an emotional tribute to Lindsay May Palevsky, who died in November 2024 following a years-long battle ...
Nuclidium has raised 79 million Swiss francs ($99 million) as the Swiss and German biotech looks to continue the clinical ...
Kim Kardashian is remembering one of her closest childhood friends eight months after her death. In a touching tribute post ...
Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...
Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...
1d
India Today on MSNWhat is PET-CT Imaging? Know types, use and beyondPET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...
ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...
The team recommended PRRT (Peptide Receptor Radionuclide Therapy), a therapy that delivers radiation directly to cancer cells ...
5don MSN
Danielle Walker, 36, plans to undergo immunotherapy treatment in Germany which costs £35,000 a course :: The family has ...
Proceeds will fund further clinical development of the company's true theranostic pipeline and expansion of the global production and ma ...
ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a ...
Lantheus Holdings offers a compelling bull case, with PYLARIFY and DEFINITY driving valuation and strong growth prospects.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results